Windlas Biotech is a Pharma company which provides CDMO service with Market cap pf 881 Cr. P/E 18.8 vs Industry P/E 32 Quarterly sale & operating profit is improving
Technically Chart has completed it cup handle pattern and given the breakout which is been retested. Look good to accumulate for ATH Target. one can expect 30 to 40% from this.
Trade active
It is trading at 415. Retesting it neckline . once retest is completed it shall move for its first target of 490.
Stop loss should be 395 on closing basis.
Not a stock recommendation . It is for educational purpose.
Trade active
It has come down to 403. strong accumulation is going on in this stock. As a investor one should be happy accumulate at lower levels.
It is for educational purpose. consult your financial advisor before investing.
Trade active
It has jumped more than 11% taking the price to 476. Today it has made a ATH of 500.some profit booking might be there.
Now 450 -466 should act as a support.
Not a Buy/Sell Recommendation.
Trade active
It is trading at 498. Made a all time high of 544.
466 should be kept as SL on closing basis.
Still long way to go
This is for Educational Purpose. Not a Buy/Sell Recommendation.
Trade active
It is trading at 484 now.
440 to 460 is good price to accumulate it for higher target
This is for Educational Purpose. Not a Buy/Sell Recommendation.
Trade active
It is trading at 468.
It is still in upward trend. If it breakdown it will be a oppurtunity to accumulate it.
Final Stop loss should be 405 on closing basis.
This is for Educational Purpose. Not a Buy/Sell Recommendation.
Trade active
It is trading at 547. Following the uptrend channel.
It is unable to give closing above it resistance of 558.
Trade active
Now it is at 580.
602 will be the target for cup and handle pattern breakout..smoothly it is in upward channel.
Still more to go
Trade closed: target reached
Our target has been achieved now.
congratulations to all those who have patiently Hold it in the downfall.
one can book the amount they have invested and leave the other part to grow.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.